| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.001 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.001 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.23 | 0.001 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.089 | 0.001 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |